Experimental: ALZ-801 clinical trials

Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects

This study looks at the long-term safety and effects of a drug called ALZ-801 for people with early Alzheimer's disease who have a specific genetic make-up (APOE4/4). It's an ongoing study where all participants receive the active drug. The aim is to see how well it works and if it's safe over a longer period.